Tadalafil Tablet, Film Coated
Product Images NDC 63629-8157

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 63629-8157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636298157)

Label for Tadalafil 10 mg tablet, film coated, packaged by Bryant Ranch Prepack in Burbank, CA. The label compares to Cialis 10 mg tablet by Sun Pharmaceutical Industries Inc. It includes storage instructions to keep at 20°-25°C and a warning to keep drugs out of reach of children. The package contains 30 tablets and displays a barcode and lot number 1523487.*

FDA Label Image

Spl-tadalafil-figure-1 (Spl Tadalafil Figure 1)

A set of four line graphs showing changes in blood pressure over time in hours (0 to 96). The graphs illustrate the difference in systolic and diastolic blood pressure between Tadalafil and placebo subjects while standing and supine. Each graph plots blood pressure difference (mmHg) on the vertical axis against time on the horizontal axis, including error bars.*

FDA Label Image

Spl-tadalafil-figure-2 (Spl Tadalafil Figure 2)

A dual line graph depicting the effects of Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg on standing and supine systolic blood pressure (mmHg) over 24 hours post-dose. The top graph shows standing systolic BP changes, while the bottom graph shows supine systolic BP changes, tracking variations from 0 to 24 hours after dosing.*

FDA Label Image

Spl-tadalafil-figure-3 (Spl Tadalafil Figure 3)

A line graph depicting changes in systolic blood pressure (mmHg) over 12 hours following administration of 20 mg tadalafil or placebo alongside 8 mg doxazosin at 08:00 or 20:00. Four data series compare systolic BP effects by treatment and administration time.*

FDA Label Image

Spl-tadalafil-figure-4 (Spl Tadalafil Figure 4)

A line graph showing plasma tadalafil concentration (µg/L) over time (hours) for three dosing regimens: single 20-mg dose, single 5-mg dose, and once-daily 5-mg dose following 5 consecutive days of administration. Concentration peaks early then declines, with error bars indicating variability.*

FDA Label Image

Spl-tadalafil-figure-5 (Spl Tadalafil Figure 5)

A line graph showing the change from baseline in IPSS total score over 12 weeks of treatment comparing Tadalafil 5 mg and placebo. The x-axis represents duration of treatment in weeks, and the y-axis represents change from baseline in IPSS total score. Tadalafil 5 mg shows a greater reduction in score over time compared to placebo.*

FDA Label Image

Spl-tadalafil-figure-6 (Spl Tadalafil Figure 6)

A line graph showing change from baseline in IPSS Total Score over 12 weeks of treatment comparing Tadalafil 5 mg to placebo. The x-axis represents duration of treatment in weeks (0, 1, 4, 8, 12), and the y-axis shows score change ranging from 0 to -6. The Tadalafil 5 mg group shows a greater decrease in score over time compared to placebo, with statistically significant differences (p<0.01) at weeks 4 and 12.*

FDA Label Image

Spl-tadalafil-figure-8 (Spl Tadalafil Figure 8)

A line graph depicting change from baseline in IPSS Total Score over a 12-week treatment duration comparing Tadalafil 5 mg and placebo. The graph shows a greater decrease in total symptom score for Tadalafil 5 mg relative to placebo across the treatment weeks, with statistically significant difference noted at 12 weeks (p<0.01).*

FDA Label Image

Spl-tadalafil-structure (Spl Tadalafil Structure)

Chemical structure of tadalafil, depicting its molecular framework with rings and functional groups as illustrated in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.